Equillium to Participate in Upcoming Investor Conferences

Core Insights - Equillium, Inc. is a clinical-stage biotechnology company focused on developing novel therapeutics for severe autoimmune and inflammatory disorders [4] Upcoming Investor Conferences - Equillium management will participate in the Stifel Healthcare Conference on November 12, 2025, from 3:20-3:50 PM EDT, featuring a company presentation and one-on-one meetings [1] - The company will also attend the Jefferies Global Healthcare Conference in London from November 18 to November 20, 2025, where management will be available for one-on-one meetings with registered investors [2] Presentation Access - Investors and the public can access a live webcast of the presentations on the Events & Presentations page of Equillium's website, with an archived replay available for 90 days [3]